다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
Cardiovascular therapeutics, v.34 no.5, 2016년, pp.371 - 382
Kim, Kyung‐Jin (Division of Cardiology Department of Internal Medicine Seoul National University Hospital Seoul National University College of Medicine Seoul Korea) , Kim, Sang‐Hyun (Division of Cardiology Department of Internal Medicine Boramae Medical Center Seoul National University College of Medicine Seoul Korea) , Yoon, Young Won (Division of Cardiology Department of Internal Medicine Gangnam Severance Hospital Yonsei University College of Medicine Seoul Korea) , Rha, Seung‐Woon (Department of Internal Medicine Medical College Korea University Seoul Korea) , Hong, Soon‐Jun (Division of Cardiology Department of Cardiovascular Center Korea University Anam Hospital Seoul Korea) , Kwak, Choong‐Hwan (Division of Cardiology Department of Cardiovascular Center Gyeongsang National University Hospital Jinju Korea) , Kim, Weon (Cardiovascular Department of Internal Medicine Kyung Hee University Hospital Seoul Korea) , Nam, Chang‐Wook (Division) , Rhee, Moo‐Yong , Park, Tae‐Ho , Hong, Taek‐Jong , Park, Sungha , Ahn, Youngkeun , Lee, Namho , Jeon, Hui‐Kyung , Jeon, Dong‐Woon , Han, Kyoo‐Rok , Moon, Keon‐Woong , Chae, In‐Ho , Kim, Hyo‐soo
AI-Helper
SummaryAimWe aimed to compare the effects of fixed‐dose combinations of ezetimibe plus rosuvastatin to rosuvastatin alone in patients with primary hypercholesterolemia, including a subgroup analysis of patients with diabetes mellitus (DM) or metabolic syndrome (MetS).MethodThis multicenter ei...
1 National Cholesterol Education Program Expert Panel on Detection Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) . Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report . Circulation . 2002 ; 106 : 3143 – 3421 . 12485966
2 Grundy SM , Cleeman JI , Merz CN , et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines . Circulation . 2004 ; 110 : 227 – 239 . 15249516
3 Smith MEB , Lee NJ , Haney E , Carson S . Drug class review: HMG‐CoA reductase inhibitors (statins) . Drug Class Review . 2009 [Internet]. Update 5. http://www.ohsu.edu/drugeffectiveness/reports/final.cfm . Accessed November 1, 2015.
4 Heart Protection Study Collaborative Group . MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high‐risk individuals: a randomised placebo‐controlled trial . Lancet . 2002 ; 360 : 7 – 22 . 12114036
5 Cannon CP , Braunwald E , McCabe CH , et al. Intensive versus moderate lipid lowering with statins after acute coronary syndromes . N Engl J Med . 2004 ; 350 : 1495 – 1504 . 15007110
6 LaRosa JC , Grundy SM , Waters DD , et al. Intensive lipid lowering with atorvastatin in patients with stable coronary disease . N Engl J Med . 2005 ; 352 : 1425 – 1435 . 15755765
7 Pedersen TR , Faergeman O , Kastelein JJ , et al. High‐dose atorvastatin vs usual‐dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial . JAMA . 2005 ; 294 : 2437 – 2445 . 16287954
8 Kastelein JJ , Akdim F , Stroes ES , et al. Simvastatin with or without ezetimibe in familial hypercholesterolemia . N Engl J Med . 2008 ; 358 : 1431 – 1443 . 18376000
9 Pearson TA , Laurora I , Chu H , Kafonek S . The lipid treatment assessment project (L‐TAP): a multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid‐lowering therapy and achieving low‐density lipoprotein cholesterol goals . Arch Intern Med . 2000 ; 160 : 459 – 467 . 10695686
10 Ballantyne CM , Houri J , Notarbartolo A , et al. Effect of ezetimibe coadministered with atorvastatin in 628 patients with primary hypercholesterolemia: a prospective, randomized, double‐blind trial . Circulation . 2003 ; 107 : 2409 – 2415 . 12719279
11 Armitage J . The safety of statins in clinical practice . Lancet . 2007 ; 370 : 1781 – 1790 . 17559928
12 Hamilton‐Craig I , Kostner K , Colquhoun D , Woodhouse S . Combination therapy of statin and ezetimibe for the treatment of familial hypercholesterolemia . Vasc Health Risk Manag . 2010 ; 6 : 1023 – 1037 . 21127699
13 Davidson MH , McGarry T , Bettis R , et al. Ezetimibe coadministered with simvastatin in patients with primary hypercholesterolemia . J Am Coll Cardiol . 2002 ; 40 : 2125 – 2134 . 12505224
14 Van Heek M , France CF , Compton DS , et al. In vivo metabolism‐based discovery of a potent cholesterol absorption inhibitor, SCH58235, in the rat and rhesus monkey through the identification of the active metabolites of SCH48461 . J Pharmacol Exp Ther . 1997 ; 283 : 157 – 163 . 9336320
15 Davis HR Jr , Hoos LM , Tetzloff G , et al. Deficiency of Niemann‐Pick C1 Like 1 prevents atherosclerosis in ApoE‐/‐ mice . Arterioscler Thromb Vasc Biol . 2007 ; 27 : 841 – 849 . 17218600
16 Altmann SW , Davis HR Jr , Zhu LJ , et al. Niemann‐Pick C1 Like 1 protein is critical for intestinal cholesterol absorption . Science . 2004 ; 303 : 1201 – 1204 . 14976318
17 Betters JL , Yu L . NPC1L1 and cholesterol transport . FEBS Lett . 2010 ; 584 : 2740 – 2747 . 20307540
18 Huff MW , Pollex RL , Hegele RA . NPC1L1: evolution from pharmacological target to physiological sterol transporter . Arterioscler Thromb Vasc Biol . 2006 ; 26 : 2433 – 2438 . 16973966
19 Bays HE , Davidson MH , Massaad R , et al. Safety and efficacy of ezetimibe added on to rosuvastatin 5 or 10 mg versus up‐titration of rosuvastatin in patients with hypercholesterolemia (the ACTE Study) . Am J Cardiol . 2011 ; 108 : 523 – 530 . 21596364
20 Ballantyne CM , Weiss R , Moccetti T , et al. Efficacy and safety of rosuvastatin 40 mg alone or in combination with ezetimibe in patients at high risk of cardiovascular disease (results from the EXPLORER study) . Am J Cardiol . 2007 ; 99 : 673 – 680 . 17317370
21 Cannon CP , Blazing MA , Giugliano RP , et al. Ezetimibe added to statin therapy after acute coronary syndromes . N Engl J Med . 2015 ; 372 : 2387 – 2397 . 26039521
22 Expert Panel on Detection E, Treatment of High Blood Cholesterol in Adults . Executive summary of the Third Report of The National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) . JAMA . 2001 ; 285 : 2486 – 2497 . 11368702
23 American Diabetes Association . Standards of medical care in diabetes–2014 . Diabetes Care . 2014 ; 37 ( Suppl 1 ): S14 – S80 . 24357209
24 Alberti K , Eckel RH , Grundy SM , et al. Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity . Circulation . 2009 ; 120 : 1640 – 1645 . 19805654
25 Jones PH , Davidson MH , Stein EA , et al. Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR* Trial) . Am J Cardiol . 2003 ; 92 : 152 – 160 . 12860216
26 Schuster H , Barter PJ , Stender S , et al. Effects of switching statins on achievement of lipid goals: Measuring Effective Reductions in Cholesterol Using Rosuvastatin Therapy (MERCURY I) study . Am Heart J . 2004 ; 147 : 705 – 713 . 15077101
27 Clearfield MB , Amerena J , Bassand JP , et al. Comparison of the efficacy and safety of rosuvastatin 10 mg and atorvastatin 20 mg in high‐risk patients with hypercholesterolemia–Prospective study to evaluate the Use of Low doses of the Statins Atorvastatin and Rosuvastatin (PULSAR) . Trials . 2006 ; 7 : 35 . 17184550
28 Liao JK . Safety and efficacy of statins in Asians . Am J Cardiol . 2007 ; 99 : 410 – 414 . 17261409
29 Saito Y , Goto Y , Dane A , Strutt K , Raza A . Randomized dose‐response study of rosuvastatin in Japanese patients with hypercholesterolemia . J Atheroscler Thromb . 2003 ; 10 : 329 – 336 . 15037821
30 Mabuchi H , Nohara A , Higashikata T , et al. Clinical efficacy and safety of rosuvastatin in Japanese patients with heterozygous familial hypercholesterolemia . J Atheroscler Thromb . 2004 ; 11 : 152 – 158 . 15256766
31 Farnier M , Volpe M , Massaad R , Davies MJ , Allen C . Effect of co‐administering ezetimibe with on‐going simvastatin treatment on LDL‐C goal attainment in hypercholesterolemic patients with coronary heart disease . Int J Cardiol . 2005 ; 10 : 327 – 332 .
32 Gagne C , Bays HE , Weiss SR , et al. Efficacy and safety of ezetimibe added to ongoing statin therapy for treatment of patients with primary hypercholesterolemia . Am J Cardiol . 2002 ; 90 : 1084 – 1091 . 12423708
33 Chang SH , Wu LS , Lee CH , et al. Simvastatin‐ezetimibe combination therapy is associated with a lower rate of major adverse cardiac events in type 2 diabetics than high potency statins alone: a population‐based dynamic cohort study . Int J Cardiol . 2015 ; 190 : 20 – 25 . 25912112
34 Rosen JB , Jimenez JG , Pirags V , et al. A comparison of efficacy and safety of an ezetimibe/simvastatin combination compared with other intensified lipid‐lowering treatment strategies in diabetic patients with symptomatic cardiovascular disease . Diab Vasc Dis Res . 2013 ; 10 : 277 – 286 . 23288881
35 Ruggenenti P , Cattaneo D , Rota S , et al. Effects of combined ezetimibe and simvastatin therapy as compared with Simvastatin alone in patients with type 2 diabetes a prospective randomized double‐blind clinical trial . Diabetes Care . 2010 ; 33 : 1954 – 1956 . 20566677
36 Torimoto K , Okada Y , Mori H , et al. Efficacy of combination of Ezetimibe 10 mg and rosuvastatin 2.5 mg versus rosuvastatin 5 mg monotherapy for hypercholesterolemia in patients with type 2 diabetes . Lipids Health Dis . 2013 ; 12 : 137 . 24053480
37 Ravid Z , Bendayan M , Delvin E , et al. Modulation of intestinal cholesterol absorption by high glucose levels: impact on cholesterol transporters, regulatory enzymes, and transcription factors . Am J Physiol Gastrointest Liver Physiol . 2008 ; 295 : G873 – G885 . 18772361
38 Lally SE , Owens D , Tomkin GH . Sitosterol and cholesterol in chylomicrons of type 2 diabetic and non‐diabetic subjects: the relationship with ATP binding cassette proteins G5 and G8 and Niemann‐Pick C1‐like 1 mRNA . Diabetologia . 2007 ; 50 : 217 – 219 . 17102949
39 Denke M , Pearson T , McBride P , Gazzara RA , Brady WE , Tershakovec AM . Ezetimibe added to ongoing statin therapy improves LDL‐C goal attainment and lipid profile in patients with diabetes or metabolic syndrome . Diab Vasc Dis Res . 2006 ; 3 : 93 – 102 . 17058629
40 Simons L , Tonkon M , Masana L , et al. Effects of ezetimibe added to on‐going statin therapy on the lipid profile of hypercholesterolemic patients with diabetes mellitus or metabolic syndrome . Curr Med Res Opin . 2004 ; 20 : 1437 – 1445 . 15383192
41 Rosen JB , Ballantyne CM , Hsueh WA , et al. Influence of metabolic syndrome factors and insulin resistance on the efficacy of ezetimibe/simvastatin and atorvastatin in patients with metabolic syndrome and atherosclerotic coronary heart disease risk . Lipids Health Dis . 2015 ; 14 : 103 . 26336957
42 Robinson JG , Ballantyne CM , Grundy SM , et al. Lipid‐altering efficacy and safety of ezetimibe/simvastatin versus atorvastatin in patients with hypercholesterolemia and the metabolic syndrome (from the VYMET study) . Am J Cardiol . 2009 ; 103 : 1694 – 1702 . 19539078
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
저자가 APC(Article Processing Charge)를 지불한 논문에 한하여 자유로운 이용이 가능한, hybrid 저널에 출판된 논문
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.